首页> 美国卫生研究院文献>Drug Design Development and Therapy >A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

【2h】

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

机译：用于可切除胃癌的临床预后评分系统用于预测生存期并受益于基于紫杉醇或奥沙利铂的辅助化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundGastrectomy with D2 lymphadenectomy is a standard procedure of curative resection for gastric cancer (GC). The aim of this study was to develop a simple and reliable prognostic scoring system for GC treated with D2 gastrectomy combined with adjuvant chemotherapy.

机译：背景进行D2淋巴结清扫术的胃切除术是治愈胃癌（GC）的标准方法。这项研究的目的是开发一种简单可靠的D2胃切除术联合辅助化疗治疗GC的预后评分系统。

著录项

期刊名称 Drug Design Development and Therapy
作者
Jing Qian; Yingying Qian; Jian Wang; Bing Gu; Dong Pei; Shaohua He; Fang Zhu; Oluf Dimitri Røe; Jin Xu; Lianke Liu; Yanhong Gu; Renhua Guo; Yongmei Yin; Yongqian Shu; Xiaofeng Chen;
展开▼
作者单位

展开▼
年(卷),期 2016(10),-1
年度 2016
页码 241–258
总页数 18
原文格式 PDF
正文语种
中图分类药学;药物化学;
关键词
gastric carcinoma prognostic factor TNM classification paclitaxel oxaliplatin;

机译：胃癌;预后因素;TNM分类;紫杉醇;奥沙利铂;

相似文献

外文文献
中文文献
专利

1. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy [J] . Jing Qian, Yingying Qian, Jian Wang, Drug Design, Development and Therapy . 2016,第5期

机译：可切除胃癌的临床预后评分系统，可预测紫杉醇或奥沙利铂辅助化疗的生存率和获益
2. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy [J] . Liu Xuechao, Wu Zhiming, Lin Enzi, Clinical nutrition . 2019,第4期

机译：基于炎症，营养和肿瘤标志物的全身预测评分和载体载体预测II-III阶段胃癌患者辅助化疗的癌症患者
3. Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients [J] . Chen Li, Shi Yan, Yuan Jing, Medical oncology . 2014,第9期

机译：对胃癌切除术后胃癌患者中以多西他赛和奥沙利铂为基础的辅助化疗的评估显示，多西他赛治疗的混合印戒细胞癌患者具有明显的生存获益
4. Computer extracted features related to the spatialarrangement of tumor-infiltrating lymphocytes predict overall survival in epithelial ovarian cancer receiving adjuvant chemotherapy [C] . Sepideh Azarianpour, Germán Corredor, Kaustav Bera, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算机提取与空间相关的功能肿瘤浸润淋巴细胞的安排预测上皮性卵巢癌接受佐剂化疗的整体存活
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit [O] . Lin Li, Tai Ren, Ke Liu, 2021

机译：基于自身免疫炎症指数的预后爆压指数的开发与验证可重新胆囊癌预测生存和化疗益处
7. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy [O] . Qian, Jing, Qian, Yingying, Wang, Jian, 2016

机译：可切除胃癌的临床预后评分系统，用于预测基于紫杉醇或奥沙利铂的辅助化疗的生存率和益处

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅